STUDIO

BioStock Studio: Expres2ion’s CEO gives status update

Biotech ExpreS2ion Biotechnologies - that develops vaccines for covid-19, breast cancer, influenza and malaria - is currently conducting a rights issue of 73 million...

RECOMMENDED READING

Sprint Bioscience expands collaboration

Sprint Bioscience increases innovation power

Huddinge-based Sprint Bioscience has a long-standing collaboration with Associate Professor Julian Walfridsson to find...
Ultimovacs Q1

Ultimovacs keeps delivering in Q1

Q1 saw Norwegian immuno-oncology company Ultimovacs advance on a number of fronts. The company’s...

EVENT